Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar daithelacha (< 20) Submitted: 8/31/2011 7:52:59 AM : Underperform Start Price: $12.20 DNDN Score: +49.59

The price is too high.

Report this Post Reply

Featured Broker Partners


Advertisement